Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes.
Jide Tian(Beijing Normal University), Daniel L. Kaufman(University of California, Los Angeles), Michael Clare‐Salzler(Montreal Neurological Institute and Hospital), Alan Herschenfeld(University of California, Los Angeles), P. Lehmann(University of California, Los Angeles), Mark A. Atkinson(University of Florida), Thomas G. Forsthuber(The University of Texas at San Antonio)
Cited by 426
Related Papers
Type 1 diabetes
|The Lancet|2013|2.7k
Type 1 diabetes: new perspectives on disease pathogenesis and treatment
|The Lancet|2001|1.5k
Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
|Diabetes Care|2015|1.2k
The Pathogenesis of Insulin-Dependent Diabetes Mellitus
|New England Journal of Medicine|1994|1.1k